U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07773922) titled 'Otago Exercise Program in Chemotherapy Induced Peripheral Neuropathy' on Aug. 15.
Brief Summary: Forty-eight participants between the age of 35 to 55years patient treated with Taxane chemotherapy, will be randomly divided into two equal groups, each comprising 24 patients.
* Group (A): Consists of twenty- four patients have chemo therapy Induced peripheral Neuropathy and will receive Otago exercise plus resistance exercise 3times per week for 8weeks
* Group (B): Consists of twenty- four patients with Chemotherapy induced peripheral Neuropathy who will receive conventional physical therapy program including: resistance exercise for...